---  
layout: startup_page  
title: "Tribune Therapeutics"  
id: "tribunetx.com"  
permalink: "/tribunetherapeuticstribunetx.com03262025/"  
website: "https://www.tribunetx.com/"  
funding_round: "Series A"  
funding_amount: "€23M"  
investors: "LifeArc Ventures, Novo Holdings, HealthCap, Innovestor's Life Science Fund, Inven2, Industrifonden, Investinor"  
about: "Tribune Therapeutics is a biotechnology company developing disease-modifying therapies for fibrotic diseases. The company focuses on targeting the CCN family of proteins, which drive scar formation. Their lead program, TRX-44, is in development for treating fibrotic conditions like idiopathic pulmonary fibrosis (IPF)."  
markets: "Biotech, Therapeutics, Pharmaceuticals"  
hq: "Copenhagen, Denmark"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/tribune-therapeutics/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/tribune-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/463030-39"  

date_display: "26-Mar-2025"  
date: "2025-03-26"

# SEO Optimization  
meta_title: "Tribune Therapeutics - Series A Funding (€23M)"  
meta_description: "Tribune Therapeutics, Tribune Therapeutics is a biotechnology company developing disease-modifying therapies for fibrotic diseases. The company focuses on targeting the CCN..."  
meta_keywords: "Tribune Therapeutics, Biotech, Therapeutics, Pharmaceuticals, Series A funding"  
canonical_url: "https://startup.projectstartups.com/tribunetherapeuticstribunetx.com03262025/"  
---